Xilong Scientific Co., Ltd. (SHE:002584)
8.02
+0.24 (3.08%)
Apr 29, 2026, 1:45 PM CST
Xilong Scientific Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 709.77 | 593.21 | 559.89 | 691.01 | 769.86 |
Trading Asset Securities | - | 0.11 | - | 299.65 | 61.44 |
Cash & Short-Term Investments | 709.77 | 593.32 | 559.89 | 990.66 | 831.3 |
Cash Growth | 19.63% | 5.97% | -43.48% | 19.17% | -5.30% |
Accounts Receivable | 1,922 | 1,666 | 1,637 | 1,450 | 1,189 |
Other Receivables | 20.84 | 65.48 | 83.99 | 278.16 | 520.58 |
Receivables | 1,943 | 1,732 | 1,721 | 1,728 | 1,709 |
Inventory | 646.53 | 620.3 | 561.66 | 508.2 | 454.42 |
Prepaid Expenses | - | 0.01 | 0.03 | 0.67 | 0.2 |
Other Current Assets | 244.32 | 342.29 | 486.84 | 460.11 | 704.38 |
Total Current Assets | 3,544 | 3,288 | 3,329 | 3,688 | 3,699 |
Property, Plant & Equipment | 853.14 | 827.54 | 845.7 | 691.6 | 489.93 |
Long-Term Investments | 274.68 | 361.88 | 369.85 | 368.41 | 152.05 |
Goodwill | - | - | - | 6.54 | 375.3 |
Other Intangible Assets | 182.22 | 180.21 | 179.43 | 123.75 | 62.53 |
Long-Term Accounts Receivable | - | 2.73 | 2.73 | - | - |
Long-Term Deferred Tax Assets | 28.92 | 13.87 | 11.48 | 12.13 | 8.13 |
Long-Term Deferred Charges | 15.4 | 31.26 | 9.29 | 35.43 | 17.41 |
Other Long-Term Assets | 9.02 | 10.31 | 21.22 | 54.4 | 5.6 |
Total Assets | 4,907 | 4,716 | 4,769 | 4,980 | 4,810 |
Accounts Payable | 897.79 | 988 | 950.26 | 1,178 | 1,362 |
Accrued Expenses | 24.08 | 51.98 | 46.87 | 53.04 | 61.17 |
Short-Term Debt | 864.95 | 634.51 | 726.17 | 750.09 | 512.1 |
Current Portion of Long-Term Debt | 167.36 | 124.06 | 155.83 | 66.46 | 114.27 |
Current Portion of Leases | - | 5.85 | 9.43 | 1.72 | 7.11 |
Current Income Taxes Payable | 60.47 | 13.29 | 5.98 | 8.28 | 3.65 |
Current Unearned Revenue | 55.63 | 44.03 | 30.41 | 41.75 | 37.01 |
Other Current Liabilities | 208.18 | 125.84 | 144.8 | 242.8 | 294.39 |
Total Current Liabilities | 2,278 | 1,988 | 2,070 | 2,342 | 2,392 |
Long-Term Debt | 242.94 | 375.29 | 319.09 | 280.03 | 94.98 |
Long-Term Leases | 8.34 | 3.58 | 6.05 | 19.4 | 14.12 |
Long-Term Unearned Revenue | 48.51 | 27.69 | 12.87 | 13.72 | 2.82 |
Long-Term Deferred Tax Liabilities | 3.89 | 2.57 | 7.2 | 8.02 | - |
Other Long-Term Liabilities | 149.17 | 13.11 | - | - | - |
Total Liabilities | 2,731 | 2,410 | 2,415 | 2,663 | 2,504 |
Common Stock | 585.22 | 585.22 | 585.22 | 585.22 | 585.22 |
Additional Paid-In Capital | 682.38 | 682.38 | 682.38 | 682.38 | 682.38 |
Retained Earnings | 913.27 | 988.76 | 1,032 | 999.15 | 911.06 |
Comprehensive Income & Other | -11.37 | 43.4 | 47.9 | 43.83 | 46.91 |
Total Common Equity | 2,169 | 2,300 | 2,348 | 2,311 | 2,226 |
Minority Interest | 6.41 | 6.03 | 6.06 | 5.8 | 80.81 |
Shareholders' Equity | 2,176 | 2,306 | 2,354 | 2,316 | 2,306 |
Total Liabilities & Equity | 4,907 | 4,716 | 4,769 | 4,980 | 4,810 |
Total Debt | 1,284 | 1,143 | 1,217 | 1,118 | 742.57 |
Net Cash (Debt) | -573.82 | -549.96 | -656.68 | -127.04 | 88.73 |
Net Cash Per Share | -0.99 | -0.98 | -1.18 | -0.21 | 0.17 |
Filing Date Shares Outstanding | 567.9 | 585.22 | 585.22 | 585.22 | 585.22 |
Total Common Shares Outstanding | 567.9 | 585.22 | 585.22 | 585.22 | 585.22 |
Working Capital | 1,265 | 1,300 | 1,260 | 1,345 | 1,307 |
Book Value Per Share | 3.82 | 3.93 | 4.01 | 3.95 | 3.80 |
Tangible Book Value | 1,987 | 2,120 | 2,169 | 2,180 | 1,788 |
Tangible Book Value Per Share | 3.50 | 3.62 | 3.71 | 3.73 | 3.05 |
Buildings | - | 587.12 | 596.4 | 472.95 | 447.59 |
Machinery | - | 393.87 | 241.28 | 205.2 | 176.27 |
Construction In Progress | - | 68.24 | 207.89 | 185.53 | 12.77 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.